Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Short Communication Volume 4 Issue 3

Cancer: A Translational Biology Disease

Daniel Gandia*

Department of Cancer Medicine and IQVIA, Buenos Aires, Argentina

*Corresponding Author: Daniel Gandia, Department of Cancer Medicine and IQVIA, Buenos Aires, Argentina.

Received: December 24, 2019; Published: January 11, 2020

×

  Cancer is not only one of the most fascinating cellular diseases, but also the one more threatening one. Its incidence and prevalence are continuously rising, mainly due to DNA- damaging xenobiotics.

   Cancer Prevention is a goal of maximal priority, and early detection and treatment a current reality for some of the frequent malignancies mainly geographically- related (Cervical Cancer prevalence in underdeveloped countries).

×

References

×

Citation

Citation: Daniel Gandia. “Cancer: A Translational Biology Disease" Acta Scientific Pharmaceutical Sciences 4.3 (2020): 01.



Member In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 15, 2020.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US